Aitken-Saavedra
J, Tarquinio SBC, da Rosa WLO, Gomes APN, da Silva AF, Fernandez MS, Moreira
AG, Maturana-Ramirez A, Vasconcellos ACU. Salivary characteristics may be
associated with burning mouth syndrome? J Clin Exp Dent. 2021;13(6):e542-8.
doi:10.4317/jced.58033
https://doi.org/10.4317/jced.58033
___________
References
1.
The International Classification of Headache Disorders, 3rd edition (beta
version). Cephalalgia. 2013;33:629-808. |
|
|
|
2.
Kim MJ, Kim J, Kho HS. Comparison between burning mouth syndrome patients
with and without psychological problems. Int J Oral Maxillofac Surg.
2018;47:879-87. |
|
|
|
3.
Imura H, Shimada M, Yamazaki Y, Sugimoto K. Characteristic changes of saliva
and taste in burning mouth syndrome patients. J Oral Pathol Med.
2016;45:231-6. |
|
|
|
4.
Segal A, Wong DT. Salivary diagnostics: enhancing disease detection and
making medicine better. Eur J Dent Educ. 2008;12:22-9. |
|
|
|
5.
Soares MS, Chimenos-Küstner E, Subirá-Pifarrè C, Rodríguez de Rivera-Campillo
ME, López-López J. Association of burning mouth syndrome with xerostomia and
medicines. Med Oral Patol Oral Cir Bucal. 2005;10:301-8. PMid:16056186 |
|
|
|
6.
de Moura SA, de Sousa JM, Lima DF, Negreiros AN, Silva Fde V, da Costa LJ.
Burning mouth syndrome (BMS): sialometric and sialochemical analysis and
salivary protein profile. Gerodontology. 2007;24:173-6. |
|
|
|
7.
Amenábar JM, Pawlowski J, Hilgert JB, Hugo FN, Bandeira D, Lhüller F, et al.
Anxiety and salivary cortisol levels in patients with burning mouth syndrome:
case-control study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod.
2008;105:460-5. |
|
|
|
8.
Fox PC, Busch KA, Baum BJ. Subjective reports of xerostomia and objective
measures of salivary gland performance. J Am Dent Assoc. 1987;115:581-4. PMid:3477595 |
|
|
|
9.
Saunders JB, Degenhardt L, Reed GM, Poznyak V. Alcohol Use Disorders in
ICD-11: Past, Present, and Future. Alcohol Clin Exp Res. 2019;43:1617-31. |
|
|
|
10.
Hanas R, John G, International HBAcCC. 2010 consensus statement on the
worldwide standardization of the hemoglobin A1C measurement. Diabetes Care.
2010;33:1903-4. |
|
|
|
11.
Navazesh M. Saliva in health and disease. Journal of the California Dental
Association. 2011;39:626-8. |
|
|
|
12.
Kitasako Y, Burrow MF, Stacey M, Huq L, Reynolds EC, Tagami J. Comparative
analysis of three commercial saliva testing kits with a standard saliva
buffering test. Aust Dent J. 2008;53:140-4. |
|
|
|
13.
Gardner A, So PW, Carpenter G. Endogenous salivary citrate is associated with
enhanced rheological properties following oral capsaicin stimulation. Exp
Physiol. 2020;105:96-107. |
|
|
|
14.
Oliveira BH, Nadanovsky P. Psychometric properties of the Brazilian version
of the Oral Health Impact Profile-short form. Community Dent Oral Epidemiol.
2005;33:307-14. |
|
|
|
15.
Moghadam-Kia S, Fazel N. A diagnostic and therapeutic approach to primary
burning mouth syndrome. Clin Dermatol. 2017;35:453-60. |
|
|
|
16.
Ślebioda Z, Szponar E. Burning mouth syndrome - a common dental problem in
perimenopausal women. Prz Menopauzalny. 2014;13:198-202. |
|
|
|
17.
Salort-Llorca C, Mínguez-Serra MP, Silvestre FJ. Drug-induced burning mouth
syndrome: a new etiological diagnosis. Med Oral Patol Oral Cir Bucal.
2008;13:E167-70. PMid:18305436 |
|
|
|
18.
Mitsikostas DD, Ljubisavljevic S, Deligianni CI. Refractory burning mouth
syndrome: clinical and paraclinical evaluation, comorbiities, treatment and
outcome. J Headache Pain. 2017;18:40. |
|
|
|
19.
Banegas JR, Gijón-Conde T. [Epidemiology of hypertension]. Hipertens Riesgo
Vasc. 2017;34:2-4. |
|
|
|
20.
Moore PA, Guggenheimer J, Orchard T. Burning mouth syndrome and peripheral
neuropathy in patients with type 1 diabetes mellitus. J Diabetes
Complications. 2007;21:397-402. |
|
|
|
21.
Di Stasio D, Candotto V, Serpico R, Migliozzi R, Petruzzi M, Tammaro M, et
al. Depression and distress in burning mouth syndrome: A case control study.
J Biol Regul Homeost Agents. 2018;32:91-5. PMid:29460523 |
|
|
|
22.
Grushka M, Epstein J, Mott A. An open-label, dose escalation pilot study of
the effect of clonazepam in burning mouth syndrome. Oral Surg Oral Med Oral
Pathol Oral Radiol Endod. 1998;86:557-61. PMid:9830647 |
|
|
|
23.
Thomson WM, Chalmers JM, Spencer AJ, Ketabi M. The occurrence of xerostomia
and salivary gland hypofunction in a population-based sample of older South
Australians. Spec Care Dentist. 1999;19:20-3. |
|
|
|
24.
Fernandes CSD, Salum FG, Bandeira D, Pawlowski J, Luz C, Cherubini K.
Salivary dehydroepiandrosterone (DHEA) levels in patients with the complaint
of burning mouth: a case-control study. Oral Surgery, Oral Medicine, Oral
Pathology, Oral Radiology, and Endodontology. 2009;108:537-43. |
|
|
|
25.
Poon R, Su N, Ching V, Darling M, Grushka M. Reduction in unstimulated
salivary flow rate in burning mouth syndrome. Br Dent J. 2014;217:E14. |
|
|
|
26.
Vaidya R. Burning mouth syndrome at menopause: Elusive etiology. J Midlife
Health. 2012;3:3-4. |
|
|
|
27.
Ship JA, Grushka M, Lipton JA, Mott AE, Sessle BJ, Dionne RA. Burning mouth
syndrome: an update. Journal of the American Dental Association (1939).
1995;126:842-53. |
|
|
|
28.
Matsuo R. Role of saliva in the maintenance of taste sensitivity. Critical
reviews in oral biology and medicine: an official publication of the American
Association of Oral Biologists. 2000;11:216-2 |
|
|
|
29.
Zussman E, Yarin AL, Nagler RM. Age- and Flow-dependency of Salivary
Viscoelasticity. Journal of Dental Research. 2007;86:281-5. |
|
|
|
30.
Demyttenaere K, Ansseau M, Constant E, Albert A, Van Gassen G, van Heeringen
K. Do general practitioners and psychiatrists agree about defining cure from
depression? The DEsCRIBE™ survey. BMC Psychiatry. 2011;11:169. |